// App-Quantinova.ai

844 : Characterization of Thromboembolic Events Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Researchers

Presenter

  • Caroline I. Piatek

Principal Investigators

  • Brian Jamieson

  • Michael Vredenburg

Medical Centers

  • Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA

  • Biomarck Pharmaceuticals, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Immune thrombocytopenia

  • Venous thrombosis

  • Thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Avatrombopag

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved